Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:MAZARS Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:31061741
Beskrivelse af revisor:State-authorised public accountant
Virksomhedens regnskabsklasse:Reporting class C, large enterprise
Grundlag for konklusion (revision):BASIS FOR OPINION We conducted our audit in accordance with International requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s responsibilities for the audit of the consolidated financial statements and parent company financial statements” section of our report. We are independent of the group in accordance with the International Ethics Standards Board for Accountant’s Denmark, and we have fulfilled our ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis of our opinion.
Konklusion (revision):OPINION We have audited the consolidated financial statements and the parent company financial statements of Missionpharma A/S for the financial year 1 April 2023 – balance sheet, statement of changes in equity, cash flow statement and notes, including a summary of significant accounting policies, for both the group and the parent company, as well as consolidated statement of cash flows. The consolidated financial statements and the parent company financial statements are prepared under the Danish Financial Statements Act. In our opinion, the consolidated financial statements and parent company financial statements give a true and fair view of the company’s financial position at 31 March company’s operations for the financial year 1 April 2023 Statements Act.
Udtalelse om ledelsesberetningen (revision):STATEMENT ON MANAGEMENT’S REVIEWManagement is responsible for management’s review. Our opinion on the consolidated financial statements and parent company financial statements døs not cover management’s review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the consolidated financial statements and parent company financial statements, our responsibility is to read management’s review and, in doing so, consider whether management’s review is materially inconsistent during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether management’s review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude, that management’s review is in accordance with the consolidated financial statements and parent company financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the management’s review.